Evidence map›Paper›PMID 31885581›Full record

ReviewJournal of oncology2019

The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective.

Silvia Batista, Ana C Gregório, Andreia Hanada Otake, Nuno Couto, Bruno Costa-Silva

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Tumor-microenvironment-on-a-chip: the construction and application.Cell communication and signaling : CCS · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Silvia Batista *Champalimaud Research, Champalimaud Centre for the Unknown, 1400-038 Lisbon, Portugal.
Ana C Gregório *Champalimaud Research, Champalimaud Centre for the Unknown, 1400-038 Lisbon, Portugal.
Andreia Hanada OtakeChampalimaud Research, Champalimaud Centre for the Unknown, 1400-038 Lisbon, Portugal.ORCID https://orcid.org/0000-0003-1303-1220
Nuno CoutoChampalimaud Research, Champalimaud Centre for the Unknown, 1400-038 Lisbon, Portugal.
Bruno Costa-SilvaChampalimaud Research, Champalimaud Centre for the Unknown, 1400-038 Lisbon, Portugal.ORCID https://orcid.org/0000-0002-5932-6211
Champalimaud Foundation · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal cancers are still responsible for high numbers of cancer-related deaths despite advances in therapy. Tumor-associated cells play a key role in tumor biology, by supporting or halting tumor development through the production of extracellular matrix, growth factors, cytokines, and extracellular vesicles. Here, we review the roles of these tumor-associated cells in the initiation, angiogenesis, immune modulation, and resistance to therapy of gastrointestinal cancers. We also discuss novel diagnostic and therapeutic strategies directed at tumor-associated cells and their potential benefits for the survival of these patients.

Identifiers

PMID31885581
PMCPMC6893275
OpenAlexW2989868350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.